Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca cuts 1,400 jobs

AstraZeneca is planning to close three sites across Spain, Belgium and Sweden and cut 1,400 posts as part of an efficiency drive

AstraZeneca is planning to close three sites across Spain, Belgium and Sweden and cut 1,400 posts as part of an efficiency drive. Positions will also be lost from the company's UK facility in Macclesfield.

AstraZeneca says that new manufacturing processes will enable them to drive efficiencies across the supply chain. The site closures and job cuts, which are subject to local consultation, are due to be completed by 2013.

The company is putting further investment into its plant in China where, through the enhancement of packaging and formulation capabilities, the plant will become the packing centre for Asia Pacific.

"These moves are a continuation of AstraZeneca's programme to improve the organisation's productivity and efficiency," said David Smith, executive vice president operations, AstraZeneca. "It moves the supply process closer to the customer, responding to their requirements and improving the security of the product wherever it is bought.

"I realise these changes are difficult for our affected employees, with whom we will be consulting in the coming months. We believe these changes are necessary for the long-term strength of the business."

20th November 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics